St. Jude Children's Research Hospital
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Phase 1
Recruiting
- Conditions
- Low-Grade GliomaRecurrent Low-Grade GliomaProgressive Low-Grade Glioma
- Interventions
- First Posted Date
- 2021-06-11
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT04923126
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1
Active, not recruiting
- Conditions
- Recurrent Solid TumorRecurrent Ewing SarcomaRecurrent HepatoblastomaRecurrent NeuroblastomaRecurrent Malignant Germ Cell TumorRecurrent Peripheral Primitive Neuroectodermal TumorRefractory Malignant Germ Cell TumorRefractory Malignant Solid NeoplasmRefractory Peripheral Primitive Neuroectodermal TumorRecurrent Malignant Solid Neoplasm
- Interventions
- First Posted Date
- 2021-05-25
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 46
- Registration Number
- NCT04901702
- Locations
- 🇺🇸
Lucille Packard Children's Hospital Stanford, Palo Alto, California, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, Georgia, United States
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Phase 1
Suspended
- Conditions
- Refractory Acute Leukemia of Ambiguous LineageRefractory Acute Myeloid LeukemiaAcute Leukemia of Ambiguous Lineage in RelapseAcute Myeloid Leukemia, in Relapse
- Interventions
- Drug: methotrexate/hydrocortisone/cytarabine
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 42
- Registration Number
- NCT04898894
- Locations
- 🇺🇸
Rady Children's Hospital-San Diego, San Diego, California, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1
Recruiting
- Conditions
- OsteosarcomaNeuroblastomaDesmoplastic Small Round Cell TumorMalignant Peripheral Nerve Sheath TumorsSoft Tissue SarcomaMelanomaEwing SarcomaAdrenocortical CancerRhabdoid TumorPediatric Solid Tumor
- Interventions
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT04897321
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
Phase 1
Recruiting
- Conditions
- Acute Lymphoblastic Leukemia, in RelapsePediatric ALLAcute Lymphoblastic Leukemia, Refractory
- Interventions
- Biological: CD19-CAR(Mem) T-cellsDevice: CliniMACSProcedure: Leukapheresis
- First Posted Date
- 2021-05-11
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04881240
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Psychosocial Impact of Disclosing Cancer Predisposition Genetic Testing Results During Childhood
Completed
- Conditions
- Pediatric CancerPredisposition, Genetic
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 199
- Registration Number
- NCT04848142
- Locations
- 🇺🇸
St.Jude Children's Research Hospital, Memphis, Tennessee, United States
Peripheral Blood Stem Cell Collection From Patients With Sickle Cell Disease (SCD) Using Plerixafor
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2023-04-07
- Lead Sponsor
- St. Jude Children's Research Hospital
- Registration Number
- NCT04817345
Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors
Not Applicable
Recruiting
- Conditions
- Alopecia
- Interventions
- Device: Paxman Scalp Cooling SystemOther: Alopecia AssessmentsOther: Patient Reported Outcomes Questionnaires
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04764357
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
An Open-Label Pilot Intervention Trial to Prevent Diabetes in Prediabetic Adult Survivors of Childhood Cancer
Phase 2
Recruiting
- Conditions
- Adult ChildrenPreDiabetes
- Interventions
- Behavioral: Digital Intervention
- First Posted Date
- 2021-02-08
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04742751
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
Phase 2
Recruiting
- Conditions
- FrailtyChildhood Cancer
- Interventions
- First Posted Date
- 2021-02-02
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT04733534
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath